@article{oai:shiga-med.repo.nii.ac.jp:00003725,
 author = {飯田, 洋也 and 前平, 博充 and 森, 治樹 and 谷, 眞至 and IIDA, Hiroya and KAIBORI, Masaki and HIROKAWA, Fumitoshi and INOUE, Yoshihiro and UENO, Masaki and MATSUI, Kousuke and ISHIZAKI, Morihiko and TANAKA, Shogo and TAKEMURA, Shigekazu and NOMI, Takeo and HOKUTOU, Daisuke and NODA, Takehiro and EGUCHI, Hidetoshi and NAKAI, Takuya and MAEHIRA, Hiromitsu and MORI, Haruki and TANI, Masaji and KUBO, Shoji},
 issue = {10},
 journal = {Asian Pacific journal of cancer prevention : APJCP},
 month = {Oct},
 note = {Background:
Hepatic resection (HR) is not recommended for intermediate-stage hepatocellular carcinoma (HCC) by the Barcelona Clinic Liver Cancer criteria. We examined the prognostic factors of HR for intermediate-stage HCC and developed new HR criteria for intermediate-stage HCC., Methods:
A total of 110 patients who underwent HR without any prior treatment for intermediate-stage HCC between January 2007 and December 2012 were enrolled at eight university hospitals. The outcomes and prognostic factors of HR were evaluated to develop new HR criteria., Results:
In terms of tumor size and number, the most significant prognostic factors were within the up-to-seven criteria. Furthermore, serum albumin level ≥35 g/L and serum alpha-fetoprotein (AFP) level., Journal Article},
 pages = {2903--2911},
 title = {New Hepatic Resection Criteria for Intermediate-Stage Hepatocellular Carcinoma Can Improve Long-Term Survival: A Retrospective, Multicenter Collaborative Study.},
 volume = {21},
 year = {2020}
}